public relations | marketing communications | web design |
 |
||||||||
| Home | About us | Media | design + Print | Web design | Events | Latest News | Video Projects | Contact Us | |
|
|||||||||
| Taste of success at Pig & Poultry Marketing Awards | |||||||||
| The reputation of the KellyBronze turkey for flavour is enhanced by the latest accolade for the product, gaining the Taste of Excellence Award at the Pig & Poultry Marketing Awards at the London Marriott County Hall by the River Thames. Commenting on the second successful event for Kelly Turkeys at the awards, the judges stated: “This year Kelly Turkeys surpassed itself with another succulent bird – we were impressed by how well it cooked, the tenderness of the meat and the overall texture and taste. Again the provenance of the KellyBronze turkeys must not go overlooked, and only adds to the flavour of this product.” The presentation was made to Kelly Turkeys managing director Paul Kelly and sales and marketing manager Philip Regan by Andrew Loftus, agriculture manager of Morrison’s Supermarkets which sponsored the award. Last year Kelly Turkeys was runner-up for the award for health and welfare standards. Paul Kelly recently spoke about the importance of taste in their breeding programme when 150 poult customers visited their headquarters at Danbury, Essex. He stated: “Taste is where we see the traditional Christmas market going, with consumers able to differentiate between products in terms of flavour and eating quality as well as the lifestyle of the birds.” |
|
||||||||
| Zoetis™ looks to the future | |||||||||
| Zoetis™ is the new name for Pfizer Animal Health following an initial public offering (IPO) on the New York Stock Exchange on February 1st 2013.
The business has 60 years’ experience in the animal health sector with more than 300 product lines marketed in over 120 countries and over 9500 employees. Two thirds of its $4.2 billion revenue in 2011 came from farm animal products. Within Europe Zoetis has three research and development sites at Louvain-la-Neuve and Zaventem in Belgium and Olot in Spain, and manufacturing facilities at Catania and Medolia in Italy as well as Louvain-la-Neuve and Olot. Among the research organisations with which Zoetis is collaborating is the University of Stirling. The business has been building up its presence in the poultry sector through recent years following the acquisition of Inovoject® with its automated in ovo vaccine delivery devices and last year introduced Poulvac® E-coli, the first spray vaccine against avian pathogenic Escherichia coli (APEC) for the poultry industry to be approved in the European Union. At the launch of its vision for business in Europe, Africa and the Middle East, Alejandro Bernal, Zoetis executive vice president and area president, stated: “As the largest standalone company in the industry, we are dedicated solely to animal health and focusing on our core business so our customers can grow theirs. “We strive every day to help customers meet their real-world challenges through quality medicines and vaccines, complemented by diagnostic products, genetic tests and a range of services.” |
|
||||||||
|